Corbus Investment Portfolios

Corbus Pharmaceuticals CEO to Present at August Investor Conferences Jul 31, 2024

Corbus Pharmaceuticals Set to Present Phase 1 Clinical Data of SYS6002 at 2024 ASCO GU Jan 23, 2024